Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HYPRESS: Hydrocortisone to Prevent Septic Shock
NCT00670254Phase 3Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Jan 2009
- Primary completion
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hydrocortisone in sepsis, sponsored by Charité – Universitätsmedizin Berlin. Started Jan 2009; status: completed.
02
Drugs
hydrocortisone
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT00670254.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00670254.